LA JOLLA PHARMACEUTICAL CO (LJPC) Stock Analyst Earnings Estimates
NASDAQ:LJPC - Nasdaq - US5034596040 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 23.05M 129.13% | 33.42M 44.99% | 75.72M 126.57% | 53.839M -28.90% | 65.226M 21.15% | 77.414M 18.69% | 91.013M 17.57% | 109.141M 19.92% | |
| EBITDA YoY % growth | -105.25M 44.50% | -33M 68.65% | 23.494M 171.19% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -109.8M 43.42% | -35.84M 67.36% | 21.831M 160.91% | 2.276M -89.58% | 8.928M 292.34% | 18.247M 104.38% | 44.723M 145.10% | 111.806M 150.00% | |
| Operating Margin | -476.36% | -107.24% | 28.83% | 4.23% | 13.69% | 23.57% | 49.14% | 102.44% | |
| EPS YoY % growth | -4.30 45.57% | -1.45 66.28% | 0.57 139.31% | 0.04 -92.84% | 0.23 475.00% | 0.48 104.35% | 1.17 145.10% | 2.94 150.00% |
| Q3 / 22 | Q4 / 22 | |
|---|---|---|
| EPS Q2Q % growth | 0.04 151.00% | 0.03 -74.50% |
| Revenue Q2Q % growth | 14.545M 9.25% | 16.58M 35.79% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | 1.443M 174.91% | 3.722M 18,509.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 0.08 -27.27% | 0.00 | 0.08 | % |
| Q1 2022 Q2Q % growth | -0.15 -135.71% | 0.01 | -0.16 | -1,570.59% |
| Q4 2021 Q2Q % growth | 0.12 192.31% | 0.04 | 0.08 | 194.12% |
| Q3 2021 Q2Q % growth | -0.08 81.40% | -0.07 | -0.01 | -12.04% |
| Q2 2021 Q2Q % growth | 0.11 119.30% | -0.13 | 0.24 | 182.96% |
| Q1 2021 Q2Q % growth | 0.42 231.25% | 0.57 | -0.15 | -25.81% |
| Q4 2020 Q2Q % growth | -0.13 86.02% | -0.35 | 0.22 | 62.51% |
| Q3 2020 Q2Q % growth | -0.43 60.19% | -0.55 | 0.12 | 21.93% |
| Q2 2020 Q2Q % growth | -0.57 49.11% | -0.42 | -0.15 | -36.30% |
| Q1 2020 Q2Q % growth | -0.32 72.65% | -0.80 | 0.48 | 60.12% |
| Q4 2019 Q2Q % growth | -0.93 | -0.97 | 0.04 | 4.02% |
| Q3 2019 Q2Q % growth | -1.08 | -1.10 | 0.02 | 2.19% |
| Q2 2019 Q2Q % growth | -1.12 | -1.14 | 0.02 | 1.57% |
| Q1 2019 Q2Q % growth | -1.17 | -1.34 | 0.17 | 12.66% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 10.543M -34.35% | 13.107M | -2.564M | -19.56% |
| Q1 2022 Q2Q % growth | 10.425M -69.46% | 13.362M | -2.937M | -21.98% |
| Q4 2021 Q2Q % growth | 12.21M 11.51% | 14.312M | -2.102M | -14.68% |
| Q3 2021 Q2Q % growth | 13.314M 46.79% | 12.342M | 972K | 7.88% |
| Q2 2021 Q2Q % growth | 16.059M 176.40% | 12.138M | 3.921M | 32.30% |
| Q1 2021 Q2Q % growth | 34.14M 349.80% | 33.813M | 327K | 0.97% |
| Q4 2020 Q2Q % growth | 10.95M 51.03% | 10.34M | 610.26K | 5.90% |
| Q3 2020 Q2Q % growth | 9.07M 58.84% | 6.63M | 2.44M | 36.80% |
| Q2 2020 Q2Q % growth | 5.81M 1.93% | 8.67M | -2.86M | -32.99% |
| Q1 2020 Q2Q % growth | 7.59M 72.50% | 8.058M | -468K | -5.81% |
| Q4 2019 Q2Q % growth | 7.25M | 7.348M | -97.57K | -1.33% |
| Q3 2019 Q2Q % growth | 5.71M | 7.06M | -1.35M | -19.12% |
| Q2 2019 Q2Q % growth | 5.7M | 5.811M | -110.685K | -1.90% |
| Q1 2019 Q2Q % growth | 4.4M | 5.087M | -687.423K | -13.51% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |